Mammotome
Mammotome is a global leader in innovative solutions for breast diagnostics and therapy with over 25 years of expertise. As a pioneer of vacuum-assisted breast biopsy, the company has significantly shaped the transition from open surgical procedures to minimally invasive techniques. Today, the focus is on integrated solutions that enable efficiency gains for clinicians and patient-centered care[1][4].
Key Products
The portfolio includes systems for stereotactic, ultrasound-guided, and MRI-guided biopsies, as well as wireless localization technologies. Noteworthy are the Mammotome Revolve™ system for precise tissue sampling, the HydroMARK™ biopsy marker with extended visibility in ultrasound, and the Tru-Core™ II instrument for automated biopsies. Recently, the company has also been distributing the Pintuition® navigation system for precise lesion marking[2][4][*].
Mission and Values
Mammotome sees itself as an indispensable partner for doctors and patients. The vision: to drive Innovation through Compassion to improve breast treatment worldwide. The focus is on the needs of patients – from diagnosis to therapy support. This is reflected in the development of user-friendly technologies that optimize clinical processes while minimizing patient burden[1][3].
Global Engagement
Headquartered in Cincinnati, Ohio, Mammotome is represented in over 50 countries. As part of the Danaher Corporation, the company benefits from cross-sectoral know-how in biotechnology and diagnostics, which accelerates the development of forward-looking solutions. Through partnerships – such as the one with Sirius Medical for the Pintuition® system – Mammotome continuously expands its offering[4][*].
Continuing Education and Sustainability
The company promotes professional exchange through workshops and hands-on training on topics such as Vacuum-assisted Biopsy (VAB) and contrast-enhanced Mammography. A central goal is QUALITY ASSURANCE through training that strengthens both technical and interpersonal skills. Although sustainability goals are not explicitly mentioned, the focus on minimally invasive methods shows an implicit pursuit of resource-saving procedures[2][*].
With a team of engineers, physicians, and breast cancer survivors, Mammotome combines technological precision with clinical empathy – true to the motto: "Every moment counts when it comes to improving breast cancer diagnoses and therapies"[*][3].
(Note: The statements marked with [*] are based on additional information from the provided description.)
Scope: ≈2,300 characters
Key areas:
- Innovation history with a focus on biopsy technologies
- Product portfolio highlights and new developments
- Corporate culture as an interface between technology and patient needs
- Global networking through Danaher partnerships and training initiatives
- Implicit sustainability through minimally invasive approaches